ALM

Almirall

$13.40

+1.67%
Oct 2, 2026
Bobby Quantitative Model
Almonty Industries Inc. is a tungsten-focused mining company engaged in the extraction, processing, and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Portugal, while simultaneously developing the Sangdong Mine in South Korea — one of the world's largest undeveloped tungsten deposits outside of China — alongside early-stage projects in Spain and Montana. The company occupies a strategically distinct position as one of the few non-Chinese tungsten producers globally, at a time when Western governments are aggressively prioritizing critical mineral supply chain security. The current investor narrative is dominated by the Sangdong Mine's development timeline and its potential to become a cornerstone non-Chinese tungsten supply source, amplified by a broader geopolitical theme visible in recent headlines emphasizing $12 billion in Western critical mineral initiatives and record-high global export restrictions. However, this bullish structural thesis is being tested by persistent operational losses, negative free cash flow, and a sharp recent share price decline that has raised questions about execution risk and near-term funding needs.

People also watch

MP Materials

MP Materials

MP

Analysis
USA Rare Earth

USA Rare Earth

USAR

Analysis
Materion

Materion

MTRN

Analysis
Critical Metals Corp. Ordinary Shares

Critical Metals Corp. Ordinary Shares

CRML

Analysis
United States Antimony Corporation

United States Antimony Corporation

UAMY

Analysis

BobbyInvestment Opinion: Should I buy ALM Today?

Based on the synthesis of analyst consensus, valuation, and operational momentum, the recommendation is a speculative Hold with a bias toward accumulation on weakness. The core thesis is that Almonty offers a unique exposure to the critical minerals theme, but the current valuation and negative cash flow require a high tolerance for risk. The analyst consensus is a strong buy with an average target of $24.38, implying 82% upside, but the wide target range ($12.86 to $32.29) and the stock's 24% one-month decline suggest that near-term execution risks are not fully priced in.

Supporting evidence for a Hold includes the Q1 2026 revenue surge to $25.4 million (up 192% YoY), gross margin expansion to 51.2%, and a robust cash position of $259.9 million. However, the trailing PS of 77.2x and negative free cash flow of -$79.9 million highlight the disconnect between current fundamentals and valuation. The forward PE of 11.28x is attractive only if consensus EPS of $2.415 is achieved, which requires a successful Sangdong ramp-up. The stock's beta of 1.39 and short ratio of 2.99 indicate high volatility and potential for short-covering rallies.

The biggest risks that could invalidate the thesis are delays in Sangdong production, further equity dilution, and a decline in tungsten prices. The rating would upgrade to Buy if the company demonstrates sustained positive operating cash flow and Sangdong reaches commercial production on schedule, or if the stock pulls back to the $10-11 range, improving the risk/reward. Conversely, a downgrade to Sell would be warranted if Q2 2026 revenue fails to sustain the $25 million level or if cash burn accelerates. Relative to its history, the stock is fairly valued on a forward basis but overvalued on trailing metrics; the verdict is that ALM is a high-risk, high-reward speculative play suitable only for investors with a long time horizon and tolerance for volatility.

Sign up to view all

ALM 12-Month Price Forecast

Almonty presents a classic high-risk, high-reward speculative opportunity. The bull case is underpinned by a massive revenue inflection, improving gross margins, and a strong geopolitical tailwind as Western nations seek non-Chinese tungsten sources. However, the bear case is equally compelling: the stock trades at an extreme trailing valuation, burns cash at an alarming rate, and has negative price momentum. The forward PE of 11.28x is only attractive if consensus estimates are met, which requires flawless execution at Sangdong. Given the binary nature of the investment, a neutral stance is warranted until there is clearer evidence of Sangdong's progress. An upgrade to bullish would require sustained positive operating cash flow and confirmation of production timelines; a downgrade to bearish would follow any signs of delays or dilution.

Historical Price
Current Price $13.40
Average Target $15.70
High Target $32.29
Low Target $5.44

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Almirall's 12-month outlook, with a consensus price target around $24.37 and implied upside of +81.9% versus the current price.

Average Target

$24.37

0 analysts

Implied Upside

+81.9%

vs. current price

Analyst Count

—

covering this stock

Price Range

$13 - $32

Analyst target range

Almonty is covered by 12 analysts, and the consensus is overwhelmingly bullish with a recommendation mean of 1.18 (where 1.0 = Strong Buy) and a "strong_buy" consensus rating. The average price target is $24.38, which implies approximately +81.9% upside from the current price of $13.40 — a substantial projected return that reflects analyst confidence in the Sangdong development story. The estimated EPS average of $2.415 for the forward period, combined with estimated revenue of $1.28 billion, implies a dramatic transformation from the current trailing revenue run-rate of approximately $100 million, underscoring that the bullish consensus is predicated on a successful and rapid production ramp.

The target price range spans from a low of $12.86 to a high of $32.29, representing a spread of approximately 151% between the most bearish and most bullish scenarios — a very wide dispersion that signals high uncertainty about the company's execution trajectory. The low target of $12.86 is essentially at the current price ($13.40), implying that the most cautious analyst sees no upside and is effectively pricing in delays, cost overruns, or dilution risk at Sangdong. The high target of $32.29 assumes full commercial production, favorable tungsten pricing, and multiple expansion as the company establishes itself as a strategic non-Chinese supplier. Institutional ratings show consistent Buy/Outperform ratings from DA Davidson, Oppenheimer, and B. Riley Securities throughout 2025-2026 with no downgrades, though the most recent action (DA Davidson, July 2026) was a reiteration rather than an upgrade — suggesting analysts are holding steady but not becoming more aggressive despite the stock's 24% one-month decline.

Drowning in data?

Find the real signal!

Bulls vs Bears: ALM Investment Factors

The bull case for Almonty rests on a compelling geopolitical narrative, a dramatic revenue inflection, and an analyst consensus that implies 82% upside, while the bear case centers on extreme trailing valuation, persistent cash burn, and negative price momentum. Currently, the bear evidence appears stronger in the near term: the stock is down 24% in a month, trailing PS is 77x, and free cash flow is deeply negative. However, the single most important tension is whether Sangdong reaches commercial production on time and on budget — if it does, the forward PE of 11.28x could prove conservative; if it doesn't, the stock could retest its 52-week low of $5.435.

Bullish

  • Analyst consensus strong buy with 82% upside: 12 analysts rate ALM a strong buy (recommendation mean 1.18), with an average target price of $24.38 implying +81.9% upside from the current $13.40. The high target of $32.29 suggests even greater potential if Sangdong executes flawlessly.
  • Revenue inflection with 192% YoY growth: Q1 2026 revenue surged to $25.4 million, up approximately 192% from Q1 2025's ~$8.7 million, driven by tungsten concentrate shipment ramp-up. This demonstrates the company's ability to scale production and generate meaningful top-line growth.
  • Gross margin expansion to 51.2%: Q1 2026 gross margin reached 51.2% ($13.0 million gross profit), a dramatic improvement from Q4 2025's 15.1% and Q2 2025's negative -13.1%. This signals improving unit economics as volumes increase, critical for the Sangdong development.
  • Strategic non-Chinese tungsten supplier: With Western nations accelerating $12 billion in critical mineral initiatives and global export restrictions at record highs, Almonty is one of the few non-Chinese tungsten producers. This geopolitical tailwind provides a structural demand advantage and potential government support.

Bearish

  • Extreme valuation on trailing metrics: Trailing PS ratio of 77.2x and EV/Sales of 39.5x are vastly above the Basic Materials sector average of 1-3x. The forward PE of 11.28x relies entirely on consensus EPS of $2.415, which requires a massive earnings inflection that has not yet materialized.
  • Persistent net losses and cash burn: Q1 2026 net loss was $5.26 million (net margin -20.7%), with trailing twelve-month free cash flow at -$79.9 million. The company is burning cash to fund Sangdong, and ROE is deeply negative at -45.3%.
  • Severe earnings volatility and impairments: Q4 2025 net loss was $102.3 million, driven by $91.2 million in other expenses (likely impairments). This extreme quarterly swing highlights earnings quality risk and the potential for further write-downs.
  • Negative momentum and relative underperformance: The stock is down 24.25% over the past month and 14.70% over three months, significantly underperforming SPY. Relative strength versus SPY is -24.84% over 1 month, indicating sustained selling pressure despite the broader market's gains.

ALM Technical Analysis

Almonty's stock is in a volatile recovery-and-retracement pattern, with a 1-year price change of +117.9% that dramatically outperforms SPY's +15.0% over the same period, yet the current price of $13.40 sits only 41.9% of the way up from its 52-week low of $5.435 toward its 52-week high of $24.41. This positioning — well below the midpoint of the annual range despite a strong yearly gain — signals that the stock has surrendered a substantial portion of its earlier momentum and is now trading in the lower half of its range, which could represent either a value opportunity for believers in the Sangdong thesis or a warning of continued distribution by earlier holders. The max drawdown of -53.25% underscores the severity of the peak-to-trough decline, confirming that this is a high-volatility name where timing and risk management are paramount.

Short-term momentum is decisively negative and diverging sharply from the longer-term uptrend: the 1-month change is -24.25% and the 3-month change is -14.70%, both dramatically worse than the +117.9% 1-year gain, while the 6-month change of -12.76% further confirms that the stock peaked in the April-May 2026 period (when it traded above $23) and has been in a sustained downtrend since. Relative strength versus SPY is deeply negative across shorter horizons — -24.84% over 1 month, -18.04% over 3 months, and -30.11% over 6 months — indicating significant underperformance against the broader market during the recent decline, even though the 1-year relative strength remains positive at +102.88%. This divergence between the strong annual trend and the weak recent momentum suggests the stock is undergoing a mean-reversion correction from an overextended rally, and the absence of any meaningful bounce despite the broader market's gains (SPY +0.59% over 1 month) signals that selling pressure remains dominant.

Key technical levels are clearly defined: the 52-week low at $5.435 represents the critical support zone, while the 52-week high at $24.41 stands as the major resistance ceiling. A breakdown below the recent consolidation area around $12-13 — which has held since late September 2026 — would open the door for a retest of the July 2026 lows near $10.95, while a breakout above $18-19 would be needed to signal a genuine trend reversal. The beta of 1.39 means the stock is approximately 39% more volatile than the broader market, which, combined with a short ratio of 2.99 (indicating roughly 3 days of average volume held short), suggests that position sizing should be conservative and that short-covering could amplify any positive catalyst. The current price of $13.40 is only 2.5% above the 52-week low-to-high midpoint of $14.92, placing it in a technically neutral-to-weak zone that lacks clear directional conviction.

Beta

1.39

1.39x market volatility

Max Drawdown

-53.3%

Largest decline past year

52-Week Range

$5-$24

Price range past year

Annual Return

+117.9%

Cumulative gain past year

PeriodALM ReturnS&P 500
1m-24.3%-0.1%
3m-14.7%+2.4%
6m-12.8%+16.8%
1y+117.9%+15.0%
ytd+52.3%+12.9%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

ALM Fundamental Analysis

Almonty's revenue trajectory has been erratic and is only now showing signs of meaningful scale: Q1 2026 revenue reached $25.4 million, a dramatic jump from $8.7 million in Q4 2025, $8.7 million in Q3 2025, and $7.2 million in Q2 2025, representing approximately 192% year-over-year growth from the Q1 2025 level of roughly $8.7 million. This revenue surge appears driven by the ramp-up of tungsten concentrate shipments, though the quarterly volatility — with Q4 2025 revenue collapsing to $8.7 million after Q3 2025's $8.7 million — suggests lumpy offtake timing rather than smooth, recurring revenue. The multi-quarter trend is encouraging at the top line, but the extreme quarter-to-quarter swings make it difficult to establish a reliable growth run-rate, and investors should monitor whether Q2 2026 sustains the $25 million level or reverts to the single-digit millions.

Profitability remains deeply challenged despite the revenue improvement: Q1 2026 net income was -$5.26 million on $25.4 million in revenue, yielding a net margin of -20.7%, while the trailing twelve-month net margin stands at -4.98% and the operating margin is -89.9%. Gross margin presents a starkly different picture — Q1 2026 gross margin was 51.2% (gross profit of $13.0 million), a massive improvement from Q4 2025's 15.1% and Q2 2025's negative -13.1% — indicating that the core mining economics are improving as volumes scale, but the company is being dragged into net losses by $10.8 million in SG&A expenses, $4.94 million in interest expense, and a $4.76 million hit from other income/expenses. The Q4 2025 quarter was catastrophic, with a net loss of $102.3 million driven by $91.2 million in other expenses, likely related to non-cash impairments or write-downs, which underscores the earnings quality risk in this name.

Balance sheet and cash flow metrics reveal a company that has been heavily reliant on external financing: free cash flow for Q1 2026 was -$12.1 million (with $21.8 million in capital expenditures overwhelming $9.7 million in operating cash flow), and trailing twelve-month free cash flow is -$79.9 million, meaning the company is burning cash at a significant rate to fund the Sangdong development. The debt-to-equity ratio of 0.45 is moderate on the surface, but the current ratio of 3.89 and a cash balance of $259.9 million (as of Q1 2026) provide a substantial liquidity cushion — funded largely by $193.1 million in common stock issuance in Q4 2025 and $123.3 million in Q3 2025. ROE is deeply negative at -45.3%, and with a cash flow-to-debt ratio of just 0.057, the company's ability to service debt from operations remains thin; the investment case hinges on Sangdong reaching commercial production before the cash pile is depleted.

Quarterly Revenue

$25400000.0B

2026-03

Revenue YoY Growth

N/A

YoY Comparison

Gross Margin

51.2%

Latest Quarter

Free Cash Flow

$-79883000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Open an Account, get $2 TSLA now!

Valuation Analysis: Is ALM Overvalued?

Because Almonty's trailing net income is negative (EPS of -$0.064, net margin of -4.98%), the PE ratio is not meaningful — the trailing PE of -15.47 and EV/EBITDA of -15.39 are both negative and therefore uninformative for valuation purposes. The appropriate primary metric is the price-to-sales (PS) ratio, which stands at an extraordinary 77.2x on a trailing basis, and the EV/Sales ratio of 39.5x; however, the forward PE of 11.28x — based on consensus estimated EPS of $2.415 — tells a dramatically different story, implying the market expects a massive earnings inflection as Sangdong comes online. The gap between the trailing PS of 77.2x and the forward PE of 11.28x is one of the widest in the mining sector, signaling that the market is pricing in an almost binary transition from pre-revenue development to profitable production.

Compared to the broader Basic Materials sector, where established miners typically trade at PS ratios of 1-3x and forward PEs of 10-15x, Almonty's trailing PS of 77.2x represents a premium of roughly 2,500-7,700% — an extreme outlier that can only be justified if the forward earnings estimates materialize. The PB ratio of 7.02x is also elevated versus the sector average of approximately 1.5-2.5x, reflecting the market's capitalization of future Sangdong production rather than current book value. The forward PE of 11.28x, however, is actually in line with or slightly below sector averages, suggesting that if the company delivers on consensus estimates, the valuation is not unreasonable — the entire investment case rests on the credibility of those forward estimates.

Historically, Almonty's PS ratio has ranged from approximately 15.0x (Q2 2024) to 363.8x (Q4 2025), with the current 77.2x sitting in the middle of that wide band but well above the 2022-2024 average of roughly 20-30x. The PB ratio has ranged from 2.13x (Q1 2024) to 82.3x (Q2 2025), with the current 7.02x representing a moderate level relative to history — significantly below the Q1 2026 peak of 15.8x but above the 2024 lows. The compression from the Q1 2026 PS of 221.9x to the current 77.2x reflects both the revenue surge in Q1 2026 and the stock price decline, suggesting the valuation is normalizing as the business scales, but it remains at a level that demands flawless execution on the Sangdong development timeline.

PE

-15.5x

Latest Quarter

vs. Historical

N/A

5-Year PE Range 17x~59x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

-15.4x

Enterprise Value Multiple

Investment Risk Disclosure

Almonty's financial and operational risks are substantial. The company reported a Q1 2026 net loss of $5.26 million on $25.4 million revenue, with a trailing twelve-month free cash flow of -$79.9 million, indicating a significant cash burn rate. While the cash balance of $259.9 million provides a cushion, the company's ability to service debt from operations is thin, with a cash flow-to-debt ratio of just 0.057. Furthermore, the extreme quarterly earnings volatility — from a $102.3 million loss in Q4 2025 to a $5.26 million loss in Q1 2026 — highlights the risk of non-cash impairments and unpredictable operational performance.

Market and competitive risks are equally pronounced. The stock trades at a trailing PS of 77.2x, a massive premium to the sector average of 1-3x, leaving it vulnerable to valuation compression if growth expectations are not met. The beta of 1.39 means the stock is 39% more volatile than the market, amplifying downside during sector rotations. Additionally, while the geopolitical tailwind for critical minerals is strong, competition from other non-Chinese tungsten projects and potential shifts in government policies could erode Almonty's first-mover advantage. Recent news highlights $12 billion in Western critical mineral initiatives, but also underscores that America barely mines these metals, suggesting a crowded field of emerging competitors.

In a worst-case scenario, delays or cost overruns at Sangdong could lead to a severe liquidity crunch, forcing dilutive financing at depressed prices. If the company fails to reach commercial production before depleting its cash, the stock could plummet to its 52-week low of $5.435, representing a 59.4% decline from the current $13.40. The analyst low target of $12.86 offers little downside protection, and the max drawdown of -53.25% over the past year demonstrates the stock's capacity for rapid value destruction. A retest of the July 2026 low of $10.95 would equate to an 18.3% loss, while a full bear-case scenario could see the stock fall below $6.

FAQ

The key risks include: 1) Execution risk at Sangdong, where delays or cost overruns could force dilutive financing; 2) Financial risk, with a trailing free cash flow of -$79.9 million and a cash flow-to-debt ratio of 0.057; 3) Market risk, as the stock's beta of 1.39 and 53.25% max drawdown indicate high volatility; and 4) Competitive risk from other non-Chinese tungsten projects that could erode Almonty's first-mover advantage. The most severe risk is a liquidity crunch if Sangdong does not reach production before the cash pile is depleted.

The 12-month forecast has three scenarios: bull case (30% probability) with a target range of $24.38-$32.29, base case (50%) at $13.40-$18.00, and bear case (20%) at $5.44-$10.95. The base case is most likely, assuming Sangdong progresses with minor delays and revenue grows gradually. The key assumption is that the company avoids major dilution and achieves positive operating cash flow by late 2027. However, the wide target dispersion reflects high uncertainty, and investors should monitor quarterly results closely.

On trailing metrics, ALM is significantly overvalued, with a PS ratio of 77.2x and EV/Sales of 39.5x, compared to the Basic Materials sector average of 1-3x. However, on a forward basis, the PE of 11.28x is in line with the sector, assuming consensus EPS of $2.415 is achieved. The market is pricing in a near-binary transition from development to profitable production, so the valuation is essentially a bet on Sangdong's success. If the company delivers, the stock could be undervalued; if it stumbles, the current price offers little margin of safety.

Whether ALM is a good buy depends on your risk tolerance and time horizon. The analyst consensus is a strong buy with an average target of $24.38, implying 82% upside, but the stock trades at a trailing PS of 77.2x and has a negative free cash flow of -$79.9 million. The biggest downside risk is a retest of the 52-week low of $5.435, which would represent a 59% loss. For aggressive investors who believe in the Sangdong story and can withstand volatility, a small position could be justified, but conservative investors should wait for evidence of positive operating cash flow.

ALM is more suitable for long-term investment, given its development-stage status and the multi-year timeline for Sangdong to reach full production. The stock's high beta (1.39) and lack of dividend make it less attractive for short-term trading, unless one is skilled at timing volatility. A minimum holding period of 2-3 years is recommended to allow the Sangdong thesis to play out. Short-term traders should be aware of the negative momentum and potential for further downside, while long-term investors should focus on execution milestones and cash flow trends.